/IMUC
IMUC Stock - EOM Pharmaceuticals Holdings, Inc.
Healthcare|BiotechnologyOTC
$0.15-17.32%
$0.03 (-17.32%) • Dec 19
69
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.74
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.79
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.16
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for IMUC
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.15 – $0.15
TARGET (TP)$0.17
STOP LOSS$0.14
RISK/REWARD1:2.8
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.03
52W High$0.34
52W Low$0.01
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A |
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $-2,006,355 | $-1,654,011 | $-2,885,310 | $-2,613,460 | $-1,452,990 |
| Net Income | $-1,892,133 | $-1,612,737 | $-2,646,904 | $-2,679,170 | $-1,452,992 |
| Net Margin | N/A | N/A | N/A | N/A | N/A |
| EPS | $-0.02 | $-0.01 | $-0.02 | $-0.06 | $-0.03 |
Company Overview
EOM Pharmaceuticals Holdings, Inc. is a clinical-stage biotechnology company, which engages in the development of drugs with the potential to transform therapeutic paradigms. Its pipeline includes EOM613 and EOM147. The company was founded on March 20, 1987 and is headquartered in Montvale, NJ.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
IMUCBeat Rate
54%
Last 13 quarters
Avg Surprise
+12.3%
EPS vs Estimate
Beats / Misses
7/2
4 met exactly
Latest EPS
$-0.10
Q3 2018
EPS Surprise History
Q4 16
+20.0%
$-16.00vs$-20.00
Q1 17
-13.3%
$-13.60vs$-12.00
Q2 17
No data
Q3 17
No data
Q4 17
No data
Q1 18
No data
Q2 18
No data
Q3 18
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2018 | Aug 13, 2018 | — | $-0.10 | — | — |
Q2 2018 | May 14, 2018 | — | $-0.20 | — | — |
Q1 2018 | Mar 13, 2018 | — | $-0.10 | — | — |
Q4 2017 | Nov 21, 2017 | — | $-4.00 | — | — |
Q3 2017 | Aug 14, 2017 | — | $-10.20 | — | — |
Q2 2017 | May 15, 2017 | — | $-16.40 | — | — |
Q1 2017 | Mar 9, 2017 | $-12.00 | $-13.60 | -13.3% | ✗ MISS |
Q4 2016 | Nov 10, 2016 | $-20.00 | $-16.00 | +20.0% | ✓ BEAT |
Q3 2016 | Aug 22, 2016 | $-28.00 | $-24.00 | +14.3% | ✓ BEAT |
Q2 2016 | May 12, 2016 | $-28.00 | $-28.00 | 0.0% | = MET |
Q4 2015 | Dec 31, 2015 | — | $-21.30 | — | — |
Q4 2015 | Nov 10, 2015 | $-16.00 | $-16.00 | 0.0% | = MET |
Q3 2015 | Aug 6, 2015 | $-12.00 | $-12.00 | 0.0% | = MET |
Q2 2015 | May 11, 2015 | $-8.00 | $-16.00 | -100.0% | ✗ MISS |
Q1 2015 | Mar 9, 2015 | $-20.00 | $-16.00 | +20.0% | ✓ BEAT |
Q4 2014 | Nov 10, 2014 | $-24.00 | $-16.00 | +33.3% | ✓ BEAT |
Q3 2014 | Aug 7, 2014 | $-24.00 | $-16.00 | +33.3% | ✓ BEAT |
Q2 2014 | May 8, 2014 | $-16.00 | $-16.00 | 0.0% | = MET |
Q1 2014 | Mar 13, 2014 | $-34.00 | $0.82 | +102.4% | ✓ BEAT |
Q4 2013 | Nov 6, 2013 | $-40.00 | $-20.00 | +50.0% | ✓ BEAT |
Latest News
Loading news...
Frequently Asked Questions about IMUC
What is IMUC's current stock price?
EOM Pharmaceuticals Holdings, Inc. (IMUC) is currently trading at $0.15 per share. The stock has moved -17.32% today.
What is the analyst price target for IMUC?
No analyst price targets are currently available for this stock.
What sector is EOM Pharmaceuticals Holdings, Inc. in?
EOM Pharmaceuticals Holdings, Inc. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the OTC exchange.
What is IMUC's market cap?
EOM Pharmaceuticals Holdings, Inc. has a market capitalization of $0.02 billion, making it a small-cap company.
Does IMUC pay dividends?
No, EOM Pharmaceuticals Holdings, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorDVHGF
Devonian Health Group Inc.
$0.07
Mkt Cap: $0.0B
HMTXF
Hemostemix Inc.
$0.06
Mkt Cap: $0.0B
HOOK
HOOKIPA Pharma Inc.
$0.88
Mkt Cap: $0.0B
LVCLF
Algorae Pharmaceuticals Limited
$0.00
Mkt Cap: $0.0B
NYMXF
Nymox Pharmaceutical Corporation
$0.07
Mkt Cap: $0.0B
OXBOF
Oxford BioDynamics Plc
$0.00
Mkt Cap: $0.0B
PPCB
Propanc Biopharma, Inc.
$0.71
Mkt Cap: $0.0B
PRVCF
PreveCeutical Medical Inc.
$0.02
Mkt Cap: $0.0B
QPTFF
Quest PharmaTech Inc.
$0.01
Mkt Cap: $0.0B
SRBCF
Sirona Biochem Corp.
$0.01
Mkt Cap: $0.0B
Explore stocks similar to IMUC for comparison